These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6150103)

  • 1. Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.
    Hinderling PH; Schmidlin O; Seydel JK
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):263-87. PubMed ID: 6150103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity studies of beta-adrenoceptor blocking drugs to decrease ventricular arrhythmias in guinea pigs.
    Gortner L; Hellenbrecht D
    Arzneimittelforschung; 1988 Dec; 38(12):1796-9. PubMed ID: 2907727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    Cheymol G; Poirier JM; Carrupt PA; Testa B; Weissenburger J; Levron JC; Snoeck E
    Br J Clin Pharmacol; 1997 Jun; 43(6):563-70. PubMed ID: 9205815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents.
    Barbato F; Caliendo G; La Rotonda MI; Morrica P; Silipo C; Vittoria A
    Farmaco; 1990 Jun; 45(6):647-63. PubMed ID: 1980191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks.
    Gobburu JV; Shelver WH
    J Pharm Sci; 1995 Jul; 84(7):862-5. PubMed ID: 7562438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-pharmacokinetics relationship of quaternary ammonium compounds. Correlation of physicochemical and pharmacokinetic parameters.
    Neef C; Meijer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):111-8. PubMed ID: 6527701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents.
    Hellenbrecht D; Gortner L
    Pol J Pharmacol Pharm; 1976; 28(6):625-30. PubMed ID: 13353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs.
    Ishizaki J; Yokogawa K; Nakashima E; Ichimura F
    J Pharm Pharmacol; 1997 Aug; 49(8):768-72. PubMed ID: 9379353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of beta-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity.
    Taylor DC; Pownall R; Burke W
    J Pharm Pharmacol; 1985 Apr; 37(4):280-3. PubMed ID: 2860233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol-water partition coefficients.
    Ishizaki J; Yokogawa K; Nakashima E; Ichimura F
    J Pharm Pharmacol; 1997 Aug; 49(8):762-7. PubMed ID: 9379352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.
    Hellenbrecht D; Enenkel J
    Arzneimittelforschung; 1984; 34(9):980-3. PubMed ID: 6150722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partition and distribution coefficients of aryloxypropanolamine beta-adrenoceptor antagonists.
    Recanatini M
    J Pharm Pharmacol; 1992 Jan; 44(1):68-70. PubMed ID: 1350635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
    Workman P; Brown JM
    Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
    Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
    Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between n-octanol/water partition coefficient and liquid chromatographic retention for caffeine and its metabolites, and some structure-pharmacokinetic considerations.
    Gaspari F; Bonati M
    J Pharm Pharmacol; 1987 Apr; 39(4):252-60. PubMed ID: 2884287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
    Meier J
    Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships in drug metabolism and disposition: pharmacokinetics of N-substituted amphetamines in humans.
    Testa B; Salvesen B
    J Pharm Sci; 1980 May; 69(5):497-501. PubMed ID: 7381729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH dependence of the hydrophobicity of beta-blocker amine compounds measured by counter-current chromatography.
    Carda-Broch S; Berthod A
    J Chromatogr A; 2003 May; 995(1-2):55-66. PubMed ID: 12800922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liposome as a model membrane in correlations of partitioning with alpha-adrenoceptor agonist activities.
    Choi YW; Rogers JA
    Pharm Res; 1990 May; 7(5):508-12. PubMed ID: 1973289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.